Target ID | Target Type | Target Name | Target Organism | Activity Type | Activity Relation | Value | Unit | Reference |
---|---|---|---|---|---|---|---|---|
NPT456 | Cell Line | OVCAR-4 | Homo sapiens | GI50 | 19815.27 | nM | 22934600 | |
NPT384 | Cell Line | TK-10 | Homo sapiens | GI50 | 18923.44 | nM | 18980381 | |
NPT388 | Cell Line | NCI-H322M | Homo sapiens | GI50 | 58479.01 | nM | DrugMatrix in vitro pharmacology data | |
NPT737 | Cell Line | HUVEC | Homo sapiens | IC50 | = | 10200 | nM | PubChem BioAssay data set |
NPT170 | Cell Line | SK-MEL-28 | Homo sapiens | GI50 | 21134.89 | nM | 1360492 | |
NPT323 | Cell Line | SW-620 | Homo sapiens | GI50 | 23173.95 | nM | PubChem BioAssay data set | |
NPT392 | Cell Line | SNB-75 | Homo sapiens | GI50 | 15776.11 | nM | 20061160 | |
NPT148 | Cell Line | HCT-15 | Homo sapiens | GI50 | 25176.77 | nM | 20462230 | |
NPT399 | Cell Line | SF-295 | Homo sapiens | GI50 | 16672.47 | nM | 16408090 | |
NPT377 | Cell Line | OVCAR-3 | Homo sapiens | GI50 | 10000 | nM | 17764933 | |
NPT401 | Cell Line | 786-0 | Homo sapiens | GI50 | 25234.81 | nM | DrugMatrix in vitro pharmacology data | |
NPT1478 | Individual Protein | Vascular endothelial growth factor receptor 2 | Homo sapiens | IC50 | = | 66000 | nM | 15217276 |
NPT383 | Cell Line | SNB-19 | Homo sapiens | GI50 | 23659.2 | nM | 23611151 | |
NPT397 | Cell Line | NCI-H460 | Homo sapiens | GI50 | 18620.87 | nM | 25739048 | |
NPT402 | Cell Line | Hs-578T | Homo sapiens | GI50 | 12189.9 | nM | 25537529 | |
NPT386 | Cell Line | KM12 | Homo sapiens | GI50 | 20323.57 | nM | 24863745 | |
NPT404 | Cell Line | CCRF-CEM | Homo sapiens | GI50 | 2570.4 | nM | PubChem BioAssay data set | |
NPT147 | Cell Line | SK-MEL-2 | Homo sapiens | GI50 | 20511.62 | nM | 19097799 | |
NPT391 | Cell Line | HCC 2998 | Homo sapiens | GI50 | 16943.38 | nM | PubChem BioAssay data set | |
NPT395 | Cell Line | SF-268 | Homo sapiens | GI50 | 20701.41 | nM | 16441083 | |
NPT116 | Cell Line | HL-60 | Homo sapiens | GI50 | 3076.1 | nM | 15165148 | |
NPT380 | Cell Line | U-251 | Homo sapiens | GI50 | 1559.55 | nM | 8277312 | |
NPT398 | Cell Line | UACC-62 | Homo sapiens | GI50 | 16595.87 | nM | PubChem BioAssay data set | |
NPT375 | Cell Line | Malme-3M | Homo sapiens | GI50 | 17060.82 | nM | PubChem BioAssay data set | |
NPT381 | Cell Line | OVCAR-8 | Homo sapiens | GI50 | 20230.19 | nM | DrugMatrix in vitro pharmacology data | |
NPT373 | Cell Line | SK-MEL-5 | Homo sapiens | GI50 | 18620.87 | nM | 17403996 | |
NPT405 | Cell Line | NCI-H226 | Homo sapiens | GI50 | 19230.92 | nM | 22194678 | |
NPT139 | Cell Line | HT-29 | Homo sapiens | GI50 | 26424.09 | nM | 21930377 | |
NPT393 | Cell Line | HCT-116 | Homo sapiens | GI50 | 18706.82 | nM | 24549242 | |
NPT369 | Cell Line | ACHN | Homo sapiens | GI50 | 20844.91 | nM | 19128055 | |
NPT146 | Cell Line | SK-OV-3 | Homo sapiens | GI50 | 20844.91 | nM | 19128055 | |
NPT81 | Cell Line | A549 | Homo sapiens | GI50 | 34994.52 | nM | DrugMatrix in vitro pharmacology data | |
NPT403 | Cell Line | UACC-257 | Homo sapiens | GI50 | 19408.86 | nM | 23758051 | |
NPT407 | Cell Line | COLO 205 | Homo sapiens | GI50 | 15381.55 | nM | 18715034 | |
NPT308 | Cell Line | CAKI-1 | Homo sapiens | GI50 | 29174.27 | nM | 17503850 | |
NPT368 | Cell Line | SN12C | Homo sapiens | GI50 | 20941.12 | nM | 10650082 | |
NPT390 | Cell Line | LOX IMVI | Homo sapiens | GI50 | 24490.63 | nM | 12444692 | |
NPT385 | Cell Line | SR | Homo sapiens | GI50 | 4395.42 | nM | PubChem BioAssay data set | |
NPT458 | Cell Line | IGROV-1 | Homo sapiens | GI50 | 18238.96 | nM | 18183025 | |
NPT379 | Cell Line | HOP-62 | Homo sapiens | GI50 | 16106.46 | nM | 22037378 | |
NPT382 | Cell Line | OVCAR-5 | Homo sapiens | GI50 | 25468.3 | nM | DrugMatrix in vitro pharmacology data | |
NPT112 | Cell Line | MOLT-4 | Homo sapiens | GI50 | 2636.33 | nM | 23360215 | |
NPT389 | Cell Line | RPMI-8226 | Homo sapiens | GI50 | 10000 | nM | 25884112 | |
NPT111 | Cell Line | K562 | Homo sapiens | GI50 | 19054.61 | nM | 20055495 | |
NPT457 | Cell Line | BT-549 | Homo sapiens | GI50 | 17139.57 | nM | PubChem BioAssay data set | |
NPT455 | Cell Line | NCI-H522 | Homo sapiens | GI50 | 10256.52 | nM | 16792412 | |
NPT387 | Cell Line | M14 | Homo sapiens | GI50 | 23442.29 | nM | 11421731 | |
NPT406 | Cell Line | RXF 393 | Homo sapiens | GI50 | 18071.74 | nM | 25856683 | |
NPT6363 | Individual Protein | Elastase 1 | Homo sapiens | IC50 | = | 2720 | nM | 19708679 |
NPT378 | Cell Line | NCI/ADR-RES | Homo sapiens | GI50 | 35318.32 | nM | 26035018 | |
NPT306 | Cell Line | PC-3 | Homo sapiens | GI50 | 19769.7 | nM | 20491501 | |
NPT374 | Cell Line | SF-539 | Homo sapiens | GI50 | 23014.42 | nM | 19487444 | |
NPT370 | Cell Line | NCI-H23 | Homo sapiens | GI50 | 2393.32 | nM | Open TG-GATES in vivo data: Pathology | |
NPT367 | Cell Line | MDA-N | Homo sapiens | GI50 | 23604.78 | nM | PubChem BioAssay data set | |
NPT371 | Cell Line | UO-31 | Homo sapiens | GI50 | 21037.78 | nM | 26200131 | |
NPT400 | Cell Line | MDA-MB-435 | Homo sapiens | GI50 | 1819.7 | nM | 22624550 | |
NPT394 | Cell Line | EKVX | Homo sapiens | GI50 | 20558.91 | nM | 24016057 |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient
●  The left chart: Distribution of similarity level between NPC71260 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).
Similarity Score | Similarity Level | Natural Product ID |
---|---|---|
0.9586 | High Similarity | NPC24258 |
0.9586 | High Similarity | NPC471841 |
0.9529 | High Similarity | NPC98546 |
0.9477 | High Similarity | NPC471842 |
0.9467 | High Similarity | NPC117450 |
0.9415 | High Similarity | NPC297807 |
0.9306 | High Similarity | NPC47883 |
0.9181 | High Similarity | NPC230619 |
0.9181 | High Similarity | NPC54098 |
0.9148 | High Similarity | NPC226725 |
0.9128 | High Similarity | NPC216842 |
0.9128 | High Similarity | NPC476640 |
0.9128 | High Similarity | NPC82217 |
0.9118 | High Similarity | NPC470704 |
0.9101 | High Similarity | NPC295436 |
0.9096 | High Similarity | NPC248315 |
0.9091 | High Similarity | NPC154527 |
0.9075 | High Similarity | NPC287243 |
0.9023 | High Similarity | NPC49667 |
0.9023 | High Similarity | NPC8127 |
0.9012 | High Similarity | NPC476641 |
0.8977 | High Similarity | NPC475996 |
0.8953 | High Similarity | NPC202470 |
0.8944 | High Similarity | NPC60848 |
0.8908 | High Similarity | NPC65885 |
0.8895 | High Similarity | NPC86477 |
0.8889 | High Similarity | NPC45449 |
0.8882 | High Similarity | NPC238995 |
0.883 | High Similarity | NPC1706 |
0.883 | High Similarity | NPC263092 |
0.883 | High Similarity | NPC59295 |
0.883 | High Similarity | NPC39305 |
0.883 | High Similarity | NPC1755 |
0.88 | High Similarity | NPC37606 |
0.88 | High Similarity | NPC149846 |
0.8793 | High Similarity | NPC78830 |
0.8793 | High Similarity | NPC28042 |
0.8793 | High Similarity | NPC218533 |
0.8779 | High Similarity | NPC29411 |
0.8779 | High Similarity | NPC36320 |
0.8757 | High Similarity | NPC77179 |
0.8757 | High Similarity | NPC23553 |
0.875 | High Similarity | NPC289244 |
0.8743 | High Similarity | NPC158226 |
0.8736 | High Similarity | NPC280493 |
0.8736 | High Similarity | NPC163130 |
0.8736 | High Similarity | NPC165979 |
0.8715 | High Similarity | NPC240508 |
0.8713 | High Similarity | NPC188486 |
0.8706 | High Similarity | NPC196879 |
0.8693 | High Similarity | NPC30550 |
0.8693 | High Similarity | NPC473834 |
0.8693 | High Similarity | NPC277510 |
0.8693 | High Similarity | NPC261471 |
0.8686 | High Similarity | NPC72696 |
0.8678 | High Similarity | NPC95715 |
0.8663 | High Similarity | NPC84515 |
0.8663 | High Similarity | NPC272722 |
0.8663 | High Similarity | NPC312056 |
0.8652 | High Similarity | NPC221820 |
0.8644 | High Similarity | NPC245975 |
0.8636 | High Similarity | NPC174700 |
0.8636 | High Similarity | NPC247964 |
0.8629 | High Similarity | NPC247136 |
0.8629 | High Similarity | NPC99613 |
0.8629 | High Similarity | NPC49487 |
0.8621 | High Similarity | NPC29160 |
0.8613 | High Similarity | NPC133065 |
0.8611 | High Similarity | NPC228209 |
0.8611 | High Similarity | NPC246153 |
0.8603 | High Similarity | NPC476273 |
0.8596 | High Similarity | NPC16935 |
0.8596 | High Similarity | NPC164384 |
0.8588 | High Similarity | NPC472461 |
0.8588 | High Similarity | NPC45131 |
0.8588 | High Similarity | NPC233956 |
0.858 | High Similarity | NPC281835 |
0.858 | High Similarity | NPC109827 |
0.858 | High Similarity | NPC124470 |
0.8571 | High Similarity | NPC234331 |
0.8571 | High Similarity | NPC50394 |
0.8563 | High Similarity | NPC8070 |
0.8563 | High Similarity | NPC39306 |
0.8547 | High Similarity | NPC207467 |
0.8547 | High Similarity | NPC130955 |
0.8531 | High Similarity | NPC28589 |
0.8531 | High Similarity | NPC248593 |
0.8523 | High Similarity | NPC476279 |
0.8521 | High Similarity | NPC125300 |
0.8508 | High Similarity | NPC8927 |
0.8508 | High Similarity | NPC182693 |
0.8506 | High Similarity | NPC89131 |
0.85 | High Similarity | NPC473785 |
0.8497 | Intermediate Similarity | NPC231758 |
0.8488 | Intermediate Similarity | NPC195832 |
0.8488 | Intermediate Similarity | NPC193842 |
0.848 | Intermediate Similarity | NPC268161 |
0.847 | Intermediate Similarity | NPC240808 |
0.847 | Intermediate Similarity | NPC174486 |
0.8466 | Intermediate Similarity | NPC247973 |
0.8462 | Intermediate Similarity | NPC476170 |
0.8457 | Intermediate Similarity | NPC187923 |
0.8457 | Intermediate Similarity | NPC291110 |
0.8457 | Intermediate Similarity | NPC37183 |
0.8453 | Intermediate Similarity | NPC97523 |
0.8453 | Intermediate Similarity | NPC265795 |
0.8448 | Intermediate Similarity | NPC93739 |
0.8444 | Intermediate Similarity | NPC246877 |
0.8439 | Intermediate Similarity | NPC300680 |
0.8436 | Intermediate Similarity | NPC227906 |
0.8436 | Intermediate Similarity | NPC236327 |
0.8436 | Intermediate Similarity | NPC290304 |
0.8436 | Intermediate Similarity | NPC53917 |
0.843 | Intermediate Similarity | NPC78302 |
0.843 | Intermediate Similarity | NPC305663 |
0.843 | Intermediate Similarity | NPC176665 |
0.843 | Intermediate Similarity | NPC235215 |
0.843 | Intermediate Similarity | NPC163524 |
0.843 | Intermediate Similarity | NPC7973 |
0.843 | Intermediate Similarity | NPC472438 |
0.843 | Intermediate Similarity | NPC29841 |
0.843 | Intermediate Similarity | NPC287979 |
0.8427 | Intermediate Similarity | NPC476370 |
0.8418 | Intermediate Similarity | NPC211309 |
0.8415 | Intermediate Similarity | NPC304322 |
0.8409 | Intermediate Similarity | NPC277480 |
0.84 | Intermediate Similarity | NPC284007 |
0.84 | Intermediate Similarity | NPC110257 |
0.84 | Intermediate Similarity | NPC300984 |
0.84 | Intermediate Similarity | NPC67959 |
0.8391 | Intermediate Similarity | NPC303565 |
0.8389 | Intermediate Similarity | NPC107244 |
0.8382 | Intermediate Similarity | NPC7846 |
0.8382 | Intermediate Similarity | NPC115798 |
0.8382 | Intermediate Similarity | NPC204854 |
0.8382 | Intermediate Similarity | NPC191459 |
0.8382 | Intermediate Similarity | NPC130894 |
0.8382 | Intermediate Similarity | NPC152166 |
0.8382 | Intermediate Similarity | NPC25495 |
0.8382 | Intermediate Similarity | NPC300943 |
0.8382 | Intermediate Similarity | NPC261004 |
0.8382 | Intermediate Similarity | NPC18772 |
0.8382 | Intermediate Similarity | NPC288669 |
0.8382 | Intermediate Similarity | NPC4481 |
0.8382 | Intermediate Similarity | NPC9609 |
0.8382 | Intermediate Similarity | NPC19687 |
0.8382 | Intermediate Similarity | NPC22472 |
0.8382 | Intermediate Similarity | NPC105242 |
0.8382 | Intermediate Similarity | NPC18607 |
0.8382 | Intermediate Similarity | NPC176300 |
0.8382 | Intermediate Similarity | NPC253634 |
0.8382 | Intermediate Similarity | NPC143828 |
0.838 | Intermediate Similarity | NPC476374 |
0.838 | Intermediate Similarity | NPC310794 |
0.8372 | Intermediate Similarity | NPC474520 |
0.8372 | Intermediate Similarity | NPC98661 |
0.8372 | Intermediate Similarity | NPC245546 |
0.8372 | Intermediate Similarity | NPC200388 |
0.8372 | Intermediate Similarity | NPC43243 |
0.8372 | Intermediate Similarity | NPC100916 |
0.8372 | Intermediate Similarity | NPC266960 |
0.8372 | Intermediate Similarity | NPC247017 |
0.8372 | Intermediate Similarity | NPC55619 |
0.837 | Intermediate Similarity | NPC47905 |
0.837 | Intermediate Similarity | NPC73929 |
0.837 | Intermediate Similarity | NPC139683 |
0.8362 | Intermediate Similarity | NPC76482 |
0.8362 | Intermediate Similarity | NPC241820 |
0.8353 | Intermediate Similarity | NPC171010 |
0.8352 | Intermediate Similarity | NPC267153 |
0.8343 | Intermediate Similarity | NPC471745 |
0.8343 | Intermediate Similarity | NPC294965 |
0.8343 | Intermediate Similarity | NPC108767 |
0.8333 | Intermediate Similarity | NPC84571 |
0.8333 | Intermediate Similarity | NPC139350 |
0.8333 | Intermediate Similarity | NPC246478 |
0.8333 | Intermediate Similarity | NPC471744 |
0.8333 | Intermediate Similarity | NPC224165 |
0.8324 | Intermediate Similarity | NPC189179 |
0.8324 | Intermediate Similarity | NPC185526 |
0.8324 | Intermediate Similarity | NPC224137 |
0.8324 | Intermediate Similarity | NPC93376 |
0.8324 | Intermediate Similarity | NPC227192 |
0.8324 | Intermediate Similarity | NPC203891 |
0.8324 | Intermediate Similarity | NPC101830 |
0.8324 | Intermediate Similarity | NPC475964 |
0.8324 | Intermediate Similarity | NPC110070 |
0.8324 | Intermediate Similarity | NPC75215 |
0.8314 | Intermediate Similarity | NPC201451 |
0.8314 | Intermediate Similarity | NPC44079 |
0.8314 | Intermediate Similarity | NPC208197 |
0.8314 | Intermediate Similarity | NPC214138 |
0.8314 | Intermediate Similarity | NPC80489 |
0.8314 | Intermediate Similarity | NPC26227 |
0.8306 | Intermediate Similarity | NPC475656 |
0.8306 | Intermediate Similarity | NPC475148 |
0.8305 | Intermediate Similarity | NPC272560 |
0.8304 | Intermediate Similarity | NPC304954 |
0.8304 | Intermediate Similarity | NPC39007 |
0.8304 | Intermediate Similarity | NPC289968 |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.
●  The left chart: Distribution of similarity level between NPC71260 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).
Similarity Score | Similarity Level | Drug ID | Developmental Stage |
---|---|---|---|
0.8266 | Intermediate Similarity | NPD3882 | Suspended |
0.8239 | Intermediate Similarity | NPD6232 | Discontinued |
0.8202 | Intermediate Similarity | NPD7473 | Discontinued |
0.815 | Intermediate Similarity | NPD2801 | Approved |
0.815 | Intermediate Similarity | NPD1465 | Phase 2 |
0.8114 | Intermediate Similarity | NPD3749 | Approved |
0.8103 | Intermediate Similarity | NPD3817 | Phase 2 |
0.8079 | Intermediate Similarity | NPD1247 | Approved |
0.8057 | Intermediate Similarity | NPD4868 | Clinical (unspecified phase) |
0.8045 | Intermediate Similarity | NPD6168 | Clinical (unspecified phase) |
0.8045 | Intermediate Similarity | NPD6167 | Clinical (unspecified phase) |
0.8045 | Intermediate Similarity | NPD6166 | Phase 2 |
0.8033 | Intermediate Similarity | NPD4338 | Clinical (unspecified phase) |
0.8011 | Intermediate Similarity | NPD5844 | Phase 1 |
0.7989 | Intermediate Similarity | NPD1934 | Approved |
0.7989 | Intermediate Similarity | NPD3926 | Phase 2 |
0.7966 | Intermediate Similarity | NPD919 | Approved |
0.7956 | Intermediate Similarity | NPD3818 | Discontinued |
0.7953 | Intermediate Similarity | NPD1512 | Approved |
0.7923 | Intermediate Similarity | NPD7993 | Clinical (unspecified phase) |
0.7836 | Intermediate Similarity | NPD1511 | Approved |
0.7816 | Intermediate Similarity | NPD3226 | Approved |
0.7809 | Intermediate Similarity | NPD7075 | Discontinued |
0.7784 | Intermediate Similarity | NPD6559 | Discontinued |
0.7778 | Intermediate Similarity | NPD8397 | Clinical (unspecified phase) |
0.7771 | Intermediate Similarity | NPD6599 | Discontinued |
0.774 | Intermediate Similarity | NPD2393 | Clinical (unspecified phase) |
0.7722 | Intermediate Similarity | NPD5494 | Approved |
0.7697 | Intermediate Similarity | NPD5402 | Approved |
0.7684 | Intermediate Similarity | NPD6801 | Discontinued |
0.768 | Intermediate Similarity | NPD6959 | Discontinued |
0.765 | Intermediate Similarity | NPD7852 | Clinical (unspecified phase) |
0.764 | Intermediate Similarity | NPD7096 | Clinical (unspecified phase) |
0.7634 | Intermediate Similarity | NPD6797 | Phase 2 |
0.763 | Intermediate Similarity | NPD6799 | Approved |
0.7627 | Intermediate Similarity | NPD7411 | Suspended |
0.7596 | Intermediate Similarity | NPD7184 | Clinical (unspecified phase) |
0.7594 | Intermediate Similarity | NPD7251 | Discontinued |
0.7581 | Intermediate Similarity | NPD7074 | Phase 3 |
0.7569 | Intermediate Similarity | NPD6234 | Discontinued |
0.7553 | Intermediate Similarity | NPD7808 | Phase 3 |
0.7527 | Intermediate Similarity | NPD7054 | Approved |
0.7526 | Intermediate Similarity | NPD8055 | Clinical (unspecified phase) |
0.7513 | Intermediate Similarity | NPD7879 | Clinical (unspecified phase) |
0.75 | Intermediate Similarity | NPD920 | Approved |
0.75 | Intermediate Similarity | NPD6980 | Clinical (unspecified phase) |
0.75 | Intermediate Similarity | NPD1243 | Approved |
0.7487 | Intermediate Similarity | NPD8434 | Phase 2 |
0.7487 | Intermediate Similarity | NPD7472 | Approved |
0.7486 | Intermediate Similarity | NPD4378 | Clinical (unspecified phase) |
0.7485 | Intermediate Similarity | NPD2344 | Approved |
0.7444 | Intermediate Similarity | NPD7819 | Suspended |
0.7403 | Intermediate Similarity | NPD8443 | Clinical (unspecified phase) |
0.7391 | Intermediate Similarity | NPD7199 | Phase 2 |
0.7386 | Intermediate Similarity | NPD2534 | Approved |
0.7386 | Intermediate Similarity | NPD2533 | Approved |
0.7386 | Intermediate Similarity | NPD7410 | Clinical (unspecified phase) |
0.7386 | Intermediate Similarity | NPD2532 | Approved |
0.7363 | Intermediate Similarity | NPD7768 | Phase 2 |
0.7363 | Intermediate Similarity | NPD4966 | Approved |
0.7363 | Intermediate Similarity | NPD4965 | Approved |
0.7363 | Intermediate Similarity | NPD4967 | Phase 2 |
0.7322 | Intermediate Similarity | NPD4381 | Clinical (unspecified phase) |
0.7314 | Intermediate Similarity | NPD2309 | Approved |
0.7303 | Intermediate Similarity | NPD5403 | Approved |
0.7299 | Intermediate Similarity | NPD2800 | Approved |
0.7294 | Intermediate Similarity | NPD447 | Suspended |
0.7288 | Intermediate Similarity | NPD642 | Clinical (unspecified phase) |
0.7288 | Intermediate Similarity | NPD5401 | Approved |
0.7287 | Intermediate Similarity | NPD3751 | Discontinued |
0.7287 | Intermediate Similarity | NPD7228 | Approved |
0.7278 | Intermediate Similarity | NPD4380 | Phase 2 |
0.7257 | Intermediate Similarity | NPD3750 | Approved |
0.7251 | Intermediate Similarity | NPD1607 | Approved |
0.7249 | Intermediate Similarity | NPD7804 | Clinical (unspecified phase) |
0.7241 | Intermediate Similarity | NPD1549 | Phase 2 |
0.7241 | Intermediate Similarity | NPD970 | Clinical (unspecified phase) |
0.7235 | Intermediate Similarity | NPD943 | Approved |
0.7232 | Intermediate Similarity | NPD6143 | Clinical (unspecified phase) |
0.7231 | Intermediate Similarity | NPD4287 | Approved |
0.7216 | Intermediate Similarity | NPD6190 | Approved |
0.72 | Intermediate Similarity | NPD7421 | Clinical (unspecified phase) |
0.7198 | Intermediate Similarity | NPD37 | Approved |
0.7193 | Intermediate Similarity | NPD230 | Phase 1 |
0.7189 | Intermediate Similarity | NPD5537 | Clinical (unspecified phase) |
0.7184 | Intermediate Similarity | NPD1471 | Phase 3 |
0.7184 | Intermediate Similarity | NPD1552 | Clinical (unspecified phase) |
0.7184 | Intermediate Similarity | NPD1550 | Clinical (unspecified phase) |
0.7175 | Intermediate Similarity | NPD643 | Clinical (unspecified phase) |
0.7168 | Intermediate Similarity | NPD1510 | Phase 2 |
0.7168 | Intermediate Similarity | NPD1509 | Clinical (unspecified phase) |
0.7143 | Intermediate Similarity | NPD7435 | Discontinued |
0.7135 | Intermediate Similarity | NPD7390 | Discontinued |
0.7135 | Intermediate Similarity | NPD1240 | Approved |
0.7126 | Intermediate Similarity | NPD1551 | Phase 2 |
0.7126 | Intermediate Similarity | NPD2935 | Discontinued |
0.7086 | Intermediate Similarity | NPD2346 | Discontinued |
0.7069 | Intermediate Similarity | NPD651 | Clinical (unspecified phase) |
0.7062 | Intermediate Similarity | NPD4628 | Phase 3 |
0.7062 | Intermediate Similarity | NPD8313 | Approved |
0.7062 | Intermediate Similarity | NPD8312 | Approved |
0.7053 | Intermediate Similarity | NPD8151 | Discontinued |
0.7029 | Intermediate Similarity | NPD2796 | Approved |
0.7016 | Intermediate Similarity | NPD7893 | Clinical (unspecified phase) |
0.7 | Intermediate Similarity | NPD2403 | Approved |
0.6995 | Remote Similarity | NPD6777 | Approved |
0.6995 | Remote Similarity | NPD6779 | Approved |
0.6995 | Remote Similarity | NPD6778 | Approved |
0.6995 | Remote Similarity | NPD6782 | Approved |
0.6995 | Remote Similarity | NPD6780 | Approved |
0.6995 | Remote Similarity | NPD6781 | Approved |
0.6995 | Remote Similarity | NPD6776 | Approved |
0.6984 | Remote Similarity | NPD3787 | Discontinued |
0.6978 | Remote Similarity | NPD1653 | Approved |
0.6971 | Remote Similarity | NPD3748 | Approved |
0.6966 | Remote Similarity | NPD6398 | Clinical (unspecified phase) |
0.6954 | Remote Similarity | NPD8150 | Discontinued |
0.6941 | Remote Similarity | NPD1530 | Clinical (unspecified phase) |
0.6938 | Remote Similarity | NPD7874 | Approved |
0.6938 | Remote Similarity | NPD7875 | Clinical (unspecified phase) |
0.6931 | Remote Similarity | NPD8090 | Clinical (unspecified phase) |
0.6912 | Remote Similarity | NPD7501 | Clinical (unspecified phase) |
0.6907 | Remote Similarity | NPD5953 | Discontinued |
0.6906 | Remote Similarity | NPD7422 | Clinical (unspecified phase) |
0.6906 | Remote Similarity | NPD7004 | Clinical (unspecified phase) |
0.6905 | Remote Similarity | NPD7783 | Phase 2 |
0.6905 | Remote Similarity | NPD7782 | Clinical (unspecified phase) |
0.6901 | Remote Similarity | NPD1529 | Clinical (unspecified phase) |
0.6895 | Remote Similarity | NPD5711 | Approved |
0.6895 | Remote Similarity | NPD5710 | Approved |
0.6893 | Remote Similarity | NPD2343 | Clinical (unspecified phase) |
0.6875 | Remote Similarity | NPD2799 | Discontinued |
0.6872 | Remote Similarity | NPD1878 | Clinical (unspecified phase) |
0.6872 | Remote Similarity | NPD7240 | Approved |
0.686 | Remote Similarity | NPD7870 | Phase 2 |
0.686 | Remote Similarity | NPD7871 | Phase 2 |
0.6845 | Remote Similarity | NPD2296 | Approved |
0.6836 | Remote Similarity | NPD5405 | Approved |
0.6836 | Remote Similarity | NPD6100 | Approved |
0.6836 | Remote Similarity | NPD5404 | Approved |
0.6836 | Remote Similarity | NPD5406 | Approved |
0.6836 | Remote Similarity | NPD5408 | Approved |
0.6836 | Remote Similarity | NPD6099 | Approved |
0.6824 | Remote Similarity | NPD1203 | Approved |
0.6821 | Remote Similarity | NPD2313 | Discontinued |
0.6821 | Remote Similarity | NPD3268 | Approved |
0.6821 | Remote Similarity | NPD3764 | Approved |
0.6812 | Remote Similarity | NPD7696 | Phase 3 |
0.6812 | Remote Similarity | NPD7698 | Approved |
0.6812 | Remote Similarity | NPD7697 | Approved |
0.6806 | Remote Similarity | NPD7229 | Phase 3 |
0.6806 | Remote Similarity | NPD6808 | Phase 2 |
0.6804 | Remote Similarity | NPD7286 | Phase 2 |
0.68 | Remote Similarity | NPD1933 | Approved |
0.6786 | Remote Similarity | NPD7685 | Pre-registration |
0.6782 | Remote Similarity | NPD6233 | Phase 2 |
0.678 | Remote Similarity | NPD4308 | Phase 3 |
0.6768 | Remote Similarity | NPD7090 | Clinical (unspecified phase) |
0.6762 | Remote Similarity | NPD7701 | Phase 2 |
0.6753 | Remote Similarity | NPD2163 | Approved |
0.6749 | Remote Similarity | NPD6534 | Approved |
0.6749 | Remote Similarity | NPD6535 | Approved |
0.6746 | Remote Similarity | NPD9269 | Phase 2 |
0.6743 | Remote Similarity | NPD1613 | Approved |
0.6743 | Remote Similarity | NPD1612 | Clinical (unspecified phase) |
0.6724 | Remote Similarity | NPD6859 | Clinical (unspecified phase) |
0.6724 | Remote Similarity | NPD411 | Approved |
0.6724 | Remote Similarity | NPD6798 | Discontinued |
0.6697 | Remote Similarity | NPD7907 | Approved |
0.6697 | Remote Similarity | NPD8155 | Clinical (unspecified phase) |
0.6684 | Remote Similarity | NPD5242 | Approved |
0.6667 | Remote Similarity | NPD5808 | Clinical (unspecified phase) |
0.6667 | Remote Similarity | NPD8127 | Discontinued |
0.6667 | Remote Similarity | NPD7801 | Approved |
0.6667 | Remote Similarity | NPD7549 | Discontinued |
0.6651 | Remote Similarity | NPD7680 | Approved |
0.665 | Remote Similarity | NPD7699 | Phase 2 |
0.665 | Remote Similarity | NPD7700 | Phase 2 |
0.6648 | Remote Similarity | NPD2354 | Approved |
0.6647 | Remote Similarity | NPD9717 | Approved |
0.6628 | Remote Similarity | NPD3266 | Approved |
0.6628 | Remote Similarity | NPD3267 | Approved |
0.6619 | Remote Similarity | NPD8320 | Phase 1 |
0.6619 | Remote Similarity | NPD8319 | Approved |
0.6618 | Remote Similarity | NPD7237 | Clinical (unspecified phase) |
0.6616 | Remote Similarity | NPD7039 | Approved |
0.6616 | Remote Similarity | NPD7038 | Approved |
0.661 | Remote Similarity | NPD1899 | Clinical (unspecified phase) |
0.661 | Remote Similarity | NPD6355 | Discontinued |
0.6609 | Remote Similarity | NPD6832 | Phase 2 |
0.6583 | Remote Similarity | NPD4419 | Clinical (unspecified phase) |
0.6582 | Remote Similarity | NPD7177 | Discontinued |
0.6578 | Remote Similarity | NPD7458 | Discontinued |
0.6573 | Remote Similarity | NPD6651 | Approved |
0.6571 | Remote Similarity | NPD3027 | Phase 3 |
0.6571 | Remote Similarity | NPD7095 | Approved |
0.6561 | Remote Similarity | NPD5619 | Clinical (unspecified phase) |
0.6554 | Remote Similarity | NPD4307 | Phase 2 |
0.6552 | Remote Similarity | NPD9494 | Approved |
0.655 | Remote Similarity | NPD1608 | Approved |
PubChem CID   | 382514 |
ChEMBL   | CHEMBL458248 |
ZINC   |
Molecular Weight:   | 438.06 |
ALogP:   | -2.3118 |
MLogP:   | 2.78 |
XLogP:   | 1.468 |
# Rotatable Bonds:   | 10 |
Polar Surface Area:   | 159.8 |
# H-Bond Aceptor:   | 2 |
# H-Bond Donor:   | 4 |
# Rings:   | 5 |
# Heavy Atoms:   | 32 |